MAS Global Equities
international_sharesInternational Share5yr Return
9.0%
3yr Return
16.1%
1yr Return
13.7%
3m Return
3.10%
Total Fee
0.99%
Fund Size
$182.2M
The WealthWatch View
Nearly a third of this fund sits in Australasian shares, a strikingly high home bias for an international equities portfolio. Fisher & Paykel Healthcare leads at 5.04 percent, followed by Infratil at 3.82 percent and Auckland Airport at 2.34 percent. The remaining two-thirds flows offshore, with familiar US tech names like Apple, Nvidia and Alphabet filling out the top ten. This is an all-equity fund by design, holding 99 percent in growth assets and just 2 percent in cash.
The fund placed 19th in its category over one year with a return of 13.7 percent, then climbed to 16th over three years at 16.1 percent and 11th over five years at 9.0 percent. Total fees run to 0.99 percent, with management accounting for 0.89 percent and other costs 0.09 percent. No performance fee applies. The fund holds $182.2 million in assets under management.
Medical Assurance Society runs this as a high-growth option built around global share markets, but the allocation tilts noticeably toward New Zealand and Australian companies compared with most peers in the international share category. That domestic weighting shapes the portfolio's character and sets it apart from funds that track global indices more closely.
General information only, not financial advice. Past performance is not a reliable indicator of future results.
Asset Allocation
Top Holdings
The fund's largest investments
Fisher & Paykel Healthcare Ltd
Shares · NZ
Infratil Ltd
Shares · NZ
Apple Inc
Shares · US
Nvidia Corp
Shares · US
Auckland International Airport Ltd
Shares · NZ
Alphabet Inc Class A
Shares · US
Microsoft Corp
Shares · US
Meridian Energy Limited
Shares · NZ
A2 Milk Company Ltd
Shares · NZ
JBWere Premium Custody Call Account - NZD
Cash · NZ
Historical Returns
3 Month
3.10%
1 Year
13.7%
3 Year
16.1%
annualised
5 Year
9.0%
annualised
10 Year
10.3%
Since Inception
—%
annualised
Fees
Category Rankings
Ranked within International Share funds
Risk Level
High
Fund Managers
Daniel Mead
Head of Investment
2 years, 8 months in role
Rickey Ward
Head of Investment Strategy & Research, JBWere
11 months in role
Hayden Griffiths
Head of Asset Allocation, JBWere
29 years, 11 months in role
Phil Borkin
Senior Strategist, JBWere
7 years, 3 months in role
Brendan O’Donovan
Chair Investment Committee
8 years, 9 months in role
Ready to invest?
Talk to a licensed adviser about this fund.
Get Matched